Source: www.dentistryiq.com Author: Jonathan A. Bregman, DDS, FAGD In the previous articles of this series, I discussed four barriers I see as stopping those in the dental profession from doing a complete oral cancer screening examination. In Part 1, the barrier I discussed is the overall lack of confidence in doing a complete extra-/intraoral cancer screening exam. The [...]
Continue reading...11. March 2010
Source: www.businesswire.com Author: press release The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer. Expert physicians from the National Comprehensive Cancer Network (NCCN) Member Institutions presented an update on HPV and its link to various cancers including cervical cancer, anal carcinoma, [...]
Continue reading...10. March 2010
Source: American Academy of Otolaryngology Author: Jessica Mikulski Office-based, surgeon-performed, ultrasound-guided, fine needle aspiration (FNA) of head and neck lesions yields a statistically significant higher diagnostic rate compared to the standard palpation technique, indicates new research in the March 2010 issue of Otolaryngology – Head and Neck Surgery. FNA is a diagnostic procedure used to investigate superficial lumps or [...]
Continue reading...9. March 2010
Source: www.msmagazine.com Author: Adina Nack Jorge (not his real name) feared his girlfriend would dump him. He’d been diagnosed with genital warts before meeting her, and hadn’t yet told her about his infection. Jorge was being careful—no skin-to-skin sexual contact—but the disclosure was looming. So he’d done some research and learned what caused genital warts. Armed with [...]
Continue reading...9. March 2010
Source: pharmalive.com/News Author: press release BT Pharma, a biopharmaceutical company developing innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today that it has raised EUR 13.1 million in additional funding and changed its name to Genticel. AGF Private Equity led the round, which brought in three new investors, IRDI (Institut Régional de Développement [...]
Continue reading...8. March 2010
Source: Lifestyles Author: Nicole Printz Just like the trucks on every corner in Abilene, rings on back jean pockets are a common sight. Gruen Von Behrens, who visited Abilene High School on Wednesday, knows all about smokeless tobacco. He began with snuff at 13 years old. He asked the packed high school auditorium if the students knew someone who [...]
Continue reading...6. March 2010
Source: insciences.org Author: press release Mayo Clinic researchers along with collaborators from Life Technologies are reporting on the application of a new approach for sequencing RNA to study cancer tumors. Their findings from a proof-of-principle study on oral carcinomas appear in the current issue of PLoS One, the online science journal. To explore the advantages of massively [...]
Continue reading...6. March 2010
Source: www.kptv.com Author: staff More than 30 million men take them for erectile dysfunction, but the drugs marketed to treat male impotence are now being investigated for the treatment of more than a dozen diseases and health problems. Researchers say ED drugs like Viagra could turn out to be as versatile as aspirin. They’re the images of happy [...]
Continue reading...5. March 2010
Source: featuresblogs.chicagotribune.com Author: Julie Deardorff You know you’re in a yoga or massage studio when the smell of Nag Champa incense–a blend of patchouli and sandalwood–permeates the air. But you may not want to breathe too deep. Incense contains potent pollutants, notably benzene, toluene and formaldehyde–known carcinogens found in tobacco smoke, according to the UC Berkeley Wellness [...]
Continue reading...5. March 2010
Source: Author: Christen Haigh Patients with head and neck cancers treated with transoral robotic surgery — or TORS — had good disease control, disease free survival (DFS) and overall survival (OS), according to the findings of a preliminary study presented at the Multidisciplinary Head and Neck Cancer Symposium in Chandler, Ariz. “Disease control and survival rates using [...]
Continue reading...
11. March 2010
0 Comments